Pan-Immune-Inflammation Value Predicts Wilms’ Outcomes
In a groundbreaking development that promises to redefine prognostic evaluation in pediatric oncology, researchers have unveiled the pan-immune-inflammation value (PIV) as a powerful biomarker for...